Recent Updates
Recently added Catalysts
BHST Neutral Sentiment Score: 60/100

MATERIAL CHANGE REPORT DATED FEBRUARY 14, 2025 Material Change Report dated

Key Takeaway: BioHarvest Sciences Inc. announced its voluntary delisting from the Canadian Securities Exchange (CSE), effective February 14, 2025. The company has received approval for this action, believing that the current trading volume on the CSE does not justify the costs associated with maintaining a dual listing. BioHarvest will continue to trade on the Nasdaq Global Market under the symbol 'BHST'. The management anticipates that this consolidation will improve liquidity and shareholder value.

Market Sentiment Analysis

POSITIVE FACTORS

  • Delisting is expected to streamline trading and reduce administrative burdens.
  • Consolidation of shares to Nasdaq could enhance long-term liquidity.
  • The company maintains its Nasdaq listing under 'BHST'.

CONCERNS & RISKS

  • Delisting from the CSE signifies a reduction in trading options for shareholders.
  • Potential concerns regarding perceived access to capital markets post-delisting.

Full Press Release Details

MATERIAL CHANGE REPORT
Item 1.Name and Address of Company
BIOHARVEST SCIENCES INC.
Suite 1140 - 625 Howe Street
Vancouver, BC, V6C 2T6
(the "Company" or "BioHarvest")
Item 2.Date of Material Change
The news release (the "News Release") was issued on February 10, 2025 and disseminated by Stockwatch.
Item 4.Summary of Material Change
The Company announced its delisting from the Canadian Securities Exchange ("CSE"), to be effective at close of day on February 14, 2025.
Item 5.Full Description of Material Change
The Company announced that that it has received CSE approval for a voluntary delisting of its common shares from the CSE. The delisting from the CSE will not affect the company's listing on the Nasdaq Global Market. The common shares will continue to trade on the Nasdaq under the symbol "BHST".
The company believes that the trading volume of its shares on the CSE no longer justifies the expenses, administrative efforts, and regulatory burdens required to maintain a dual listing. The company also believes that delisting from the CSE will create a central marketplace for its common shares on the Nasdaq and ultimately benefit the long-term liquidity and shareholder value of the company. For these reasons, BioHarvest's management team and Board of Directors have made the decision to voluntarily delist from the CSE, consolidating the trading of its shares to Nasdaq. All shareholders can continue trading BioHarvest's shares on Nasdaq under the symbol "BHST".
The Company is grateful to the CSE for providing its initial opportunity to access public markets.
It is expected that the close of business on Friday, February 14, 2025, will be the final trading day for BioHarvest on the CSE.
Item 6.Reliance on Subsection 7.1(2) of National Instrument 51-102
Item 7.Omitted Information
Item 8.Executive Officer
For further information, please contact:
Secretary and VP, Investor Relations
Item 9.Date of Report

Frequently Asked Questions

When did BioHarvest announce its delisting?

BioHarvest announced its delisting on February 10, 2025.

When will BioHarvest's CSE delisting take effect?

The delisting from the CSE will take effect at the close of day on February 14, 2025.

Will BioHarvest still trade on Nasdaq?

Yes, BioHarvest shares will continue trading on Nasdaq under the symbol 'BHST'.

Why is BioHarvest delisting from the CSE?

The company believes its CSE trading volume does not justify the costs of dual listing.

How will delisting affect shareholder value?

Delisting is expected to enhance liquidity and long-term shareholder value by centralizing trades.

Last updated: Feb 14, 2025